Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Stocks
Ligand Pharmaceuticals
Business Segments
Products & Services
Finance Lease, Right-of-Use Asset, after Accumulated Amortization
Finance Lease, Right-of-Use Asset, after Accumulated Amortization
Ligand Pharmaceuticals
·
Products & Services
·
1 segment
·
Rolls up to
Operating Lease ROU Assets
Breakdown
Segments
Captisol
View metric
Quarterly
Annual
TTM
Segment
Q4 '22
Q4 '23
Q4 '24
Q4 '25
Captisol
$4M
$3.4M
$2.7M
$2M
Total
$10.91M
$6.06M
$9.67M
$7.22M
